pharmaceuticals catherine boyle
The Business
21 Apr 2007
For three decades, biotech was notorious for sucking cash into a black hole. That has now changed. In 2006, worldwide revenues of listed biotechnology firms hit $70bn (£35bn, e52bn) for the first time, according to Ernst & Young. Biotech companies... read more...
posted by Bank Report at
1:57 PM
0 Comments:
Post a Comment
<< Home